EUVIMEDOpdag EUVIMED
Crossref

Structure‐Guided Engineering of Histidine‐Rich pH‐Switchable Endosomolytic Peptides for Spleen‐Selective siRNA Delivery to Inflammatory Macrophages

Dilpreet Singh iD

Journal of Peptide Science · 2026-07 · 32 (7)

DOI: 10.1002/psc.70105 ↗

At a glance

Journal article in Journal of Peptide Science, published online on 2026-05-29. Written by Dilpreet Singh. Institution: School of Pharmaceutical Sciences, CT University, Sidhwan Khurd, Punjab, India. Major MEDLINE topics: RNA, Small Interfering, Spleen, Macrophages, Histidine. 33 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Extrahepatic delivery of small interfering RNA (siRNA) remains a major translational challenge because most nanocarriers preferentially accumulate in the liver, while endosomal sequestration limits productive cytosolic release. Inflammatory macrophages in the spleen are attractive therapeutic targets in systemic inflammation, yet spleen‐selective delivery systems with efficient endosomal escape remain underdeveloped. Here, a structure‐guided peptide engineering workflow was used to generate histidine‐rich, pH‐switchable endosomolytic peptides for spleen‐selective siRNA delivery. Sequence design integrated pH‐dependent charge transition modeling, amphipathic helix prediction, membrane interaction scoring, and safety filtering. Six candidate peptides were synthesized and evaluated for pH‐responsive structure, membrane disruption, hemocompatibility, siRNA complexation, serum stability, macrophage uptake, endosomal escape, biodistribution, and anti‐inflammatory efficacy. The lead peptide, HSEP‐6, showed a predicted net charge increase from +3.1 at pH 7.4 to +7.4 at pH 5.5, helix content increasing from 17% to 56%, and acidic calcein release increasing from 9% to 62%. In inflammatory macrophages and LPS‐challenged mice, HSEP‐6 enabled efficient siRNA delivery, spleen‐selective accumulation, marked Irf5 silencing, reduced TNF‐α and IL‐6, and no measurable systemic toxicity, supporting histidine‐rich pH‐switchable peptides as a rational platform for extrahepatic RNA delivery.

Subjects

MeSH terms (MEDLINE)

RNA, Small InterferingSpleenMacrophagesHistidinePeptidesProtein EngineeringAnimalsHydrogen-Ion ConcentrationMiceInflammation

Author keywords

Irf5 silencingendosomal escapeextrahepatic nanomedicinehistidine‐rich peptidesinflammatory macrophagespH‐switchable peptidessiRNAspleen‐selective delivery

Substances

RNA, Small InterferingHistidinePeptides

Authors and institutions

  • School of Pharmaceutical Sciences, CT University, Sidhwan Khurd, Punjab, India.

ORCID profiles: Dilpreet Singh

Cite

APA

Singh, D. (2026). Structure‐Guided Engineering of Histidine‐Rich pH‐Switchable Endosomolytic Peptides for Spleen‐Selective siRNA Delivery to Inflammatory Macrophages. Journal of Peptide Science, 32(7). https://doi.org/10.1002/psc.70105

Vancouver

Singh D. Structure‐Guided Engineering of Histidine‐Rich pH‐Switchable Endosomolytic Peptides for Spleen‐Selective siRNA Delivery to Inflammatory Macrophages. Journal of Peptide Science. 2026;32(7). doi:10.1002/psc.70105

BibTeX
@article{Singh2026,
  author = {Singh, Dilpreet},
  title = {Structure‐Guided Engineering of Histidine‐Rich pH‐Switchable Endosomolytic Peptides for Spleen‐Selective siRNA Delivery to Inflammatory Macrophages},
  journal = {Journal of Peptide Science},
  year = {2026},
  volume = {32},
  number = {7},
  doi = {10.1002/psc.70105}
}
Start for free →